Sandoz today inaugurated a new production site in Kundl, Austria, to bring European-made medicines to more patients.

The investment represents a €50 million expansion of the Kundl site.

The new facility and automated production lines significantly increase production capacity, with a 20% increase over the current capacity of 200 million cans per year.

Kundl now has a production capacity of 240 million cans per year, more than double the 2021 production levels.

' With a production area of 3,000 m2, the innovative technologies used now make it possible to produce an additional one billion penicillin tablets and to double the production quantity of powdered oral suspensions (POS), mainly used in pediatric treatments ' says the group.

Copyright (c) 2024 CercleFinance.com. All rights reserved.